These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9604072)

  • 1. Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure.
    Anker SD; Volterrani M; Egerer KR; Felton CV; Kox WJ; Poole-Wilson PA; Coats AJ
    QJM; 1998 Mar; 91(3):199-203. PubMed ID: 9604072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation.
    Katz SD; Rao R; Berman JW; Schwarz M; Demopoulos L; Bijou R; LeJemtel TH
    Circulation; 1994 Jul; 90(1):12-6. PubMed ID: 8025986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure.
    Anker SD; Swan JW; Volterrani M; Chua TP; Clark AL; Poole-Wilson PA; Coats AJ
    Eur Heart J; 1997 Feb; 18(2):259-69. PubMed ID: 9043843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha.
    Doehner W; Rauchhaus M; Godsland IF; Egerer K; Niebauer J; Sharma R; Cicoira M; Florea VG; Coats AJ; Anker SD
    Int J Cardiol; 2002 Apr; 83(1):73-81. PubMed ID: 11959387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
    Jondeau G; Dib JC; Dubourg O; Bourdarias JP
    Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
    von Haehling S; Schefold JC; Jankowska EA; Springer J; Vazir A; Kalra PR; Sandek A; Fauler G; Stojakovic T; Trauner M; Ponikowski P; Volk HD; Doehner W; Coats AJ; Poole-Wilson PA; Anker SD
    J Am Coll Cardiol; 2012 Feb; 59(6):585-92. PubMed ID: 22300693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
    Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity.
    De Feo S; Franceschini L; Brighetti G; Cicoira M; Zanolla L; Rossi A; Golia G; Zardini P
    Int J Cardiol; 2005 Oct; 104(3):292-7. PubMed ID: 16186059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia and Endothelial Function in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).
    Dos Santos MR; Saitoh M; Ebner N; Valentova M; Konishi M; Ishida J; Emami A; Springer J; Sandek A; Doehner W; Anker SD; von Haehling S
    J Am Med Dir Assoc; 2017 Mar; 18(3):240-245. PubMed ID: 27816483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.
    Doehner W; Bunck AC; Rauchhaus M; von Haehling S; Brunkhorst FM; Cicoira M; Tschope C; Ponikowski P; Claus RA; Anker SD
    Eur Heart J; 2007 Apr; 28(7):821-8. PubMed ID: 17353227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of exercise ventilation in clinical evaluation and risk stratification in patients with chronic heart failure.
    Jankowska EA; Pietruk-Kowalczyk J; Zymliński R; Witkowski T; Ponikowska B; Sebzda T; Rzeczuch K; Borodulin-Nadzieja L; Hańczycowa H; Banasiak W; Ponikowski P
    Kardiol Pol; 2003 Aug; 59(8):115-27; commentary 126-7. PubMed ID: 14560326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.
    Anker SD; Leyva F; Poole-Wilson PA; Kox WJ; Stevenson JC; Coats AJ
    Heart; 1997 Jul; 78(1):39-43. PubMed ID: 9290400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure.
    Williams SG; Ng LL; O'Brien RJ; Taylor S; Wright DJ; Li YF; Tan LB
    Int J Cardiol; 2005 Jul; 102(2):279-86. PubMed ID: 15982497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure.
    Satoh M; Iwasaka J; Nakamura M; Akatsu T; Shimoda Y; Hiramori K
    Eur J Heart Fail; 2004 Dec; 6(7):869-75. PubMed ID: 15556048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
    Parissis JT; Venetsanou KF; Mentzikof DG; Ziras NG; Kefalas CG; Karas SM
    Scand Cardiovasc J; 1999; 33(6):344-50. PubMed ID: 10622546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and peripheral components of chronic heart failure: determinants of exercise tolerance.
    Florea VG; Mareyev VY; Achilov AA; Popovici MI; Coats AJ; Belenkov YN
    Int J Cardiol; 1999 Jul; 70(1):51-6. PubMed ID: 10402045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
    Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue Doppler imaging adds incremental value in predicting exercise capacity in patients with congestive heart failure.
    Terzi S; Sayar N; Bilsel T; Enc Y; Yildirim A; Ciloğlu F; Yesilcimen K
    Heart Vessels; 2007 Jul; 22(4):237-44. PubMed ID: 17653517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.